Literature DB >> 19137416

Low concentration of GA activates a preconditioning response in HepG2 cells during oxidative stress-roles of Hsp90 and vimentin.

Xuemei Chen1, Hongyun Kang, Fei Zou.   

Abstract

Oxidative stress can be a significant cause of cell death and apoptosis. We performed studies in HepG2 cells to explore whether prior exposure to oxidative stress ("oxidative preconditioning") and geldanamycin (GA) treatment can protect the cell from damage caused by subsequent oxidative insults. The cells were treated with 10 nM GA for 24 h before oxidative stress. Oxidative preconditioning was achieved by 2 h exposures to H(2)O(2) (50 microM) separated by a 10-h recovery period in normal culture medium. Oxidative stress was induced by exposure to 500 microM H(2)O(2) for 24 h. The effects of GA and oxidative preconditioning were investigated on the formation of Hsp90, vimentin, insoluble vimentin aggregates, and cleavage of vimentin in a cell culture model of oxidative stress. GA treatment leads to enhanced expression of Hsp90 and vimentin and to inhibition of vimentin protein aggregation. Similar results were obtained by oxidative preconditioning. It is confirmed that low concentrations of GA protected HepG2 cells from subsequent oxidative stress by increasing the levels of Hsp90 and by alleviating the extent of cell apoptosis induced by oxidative stress, which is similar to oxidative preconditioning. However, in contrast to preconditioning, GA treatment obviously changed binding activity of Hsp90 to vimentin cleavages. All the above indicated that low concentrations of GA treatment triggered cell protection from oxidative stress. Both the level of Hsp90 and its ability to bind with vimentin were changed by low concentrations of GA and might contribute to oxidative stress protection.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19137416      PMCID: PMC2728273          DOI: 10.1007/s12192-008-0092-7

Source DB:  PubMed          Journal:  Cell Stress Chaperones        ISSN: 1355-8145            Impact factor:   3.667


  49 in total

1.  Oxidative preconditioning and apoptosis in L-cells. Roles of protein kinase B and mitogen-activated protein kinases.

Authors:  H Han; H Wang; H Long; S Nattel; Z Wang
Journal:  J Biol Chem       Date:  2001-04-30       Impact factor: 5.157

2.  Disruption of hsp90 function results in degradation of the death domain kinase, receptor-interacting protein (RIP), and blockage of tumor necrosis factor-induced nuclear factor-kappaB activation.

Authors:  J Lewis; A Devin; A Miller; Y Lin; Y Rodriguez; L Neckers; Z G Liu
Journal:  J Biol Chem       Date:  2000-04-07       Impact factor: 5.157

3.  Crystal structure of an Hsp90-geldanamycin complex: targeting of a protein chaperone by an antitumor agent.

Authors:  C E Stebbins; A A Russo; C Schneider; N Rosen; F U Hartl; N P Pavletich
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

4.  A system for stable expression of short interfering RNAs in mammalian cells.

Authors:  Thijn R Brummelkamp; René Bernards; Reuven Agami
Journal:  Science       Date:  2002-03-21       Impact factor: 47.728

5.  Geldanamycin activates a heat shock response and inhibits huntingtin aggregation in a cell culture model of Huntington's disease.

Authors:  A Sittler; R Lurz; G Lueder; J Priller; H Lehrach; M K Hayer-Hartl; F U Hartl; E E Wanker
Journal:  Hum Mol Genet       Date:  2001-06-01       Impact factor: 6.150

6.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells.

Authors:  S M Elbashir; J Harborth; W Lendeckel; A Yalcin; K Weber; T Tuschl
Journal:  Nature       Date:  2001-05-24       Impact factor: 49.962

7.  Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in Jurkat cells.

Authors:  I Belichenko; N Morishima; D Separovic
Journal:  Arch Biochem Biophys       Date:  2001-06-01       Impact factor: 4.013

8.  Changes in vimentin in human macrophages during apoptosis induced by oxidised low density lipoprotein.

Authors:  K Müller; S Dulku; S J Hardwick; J N Skepper; M J Mitchinson
Journal:  Atherosclerosis       Date:  2001-05       Impact factor: 5.162

9.  Caspase cleavage of vimentin disrupts intermediate filaments and promotes apoptosis.

Authors:  Y Byun; F Chen; R Chang; M Trivedi; K J Green; V L Cryns
Journal:  Cell Death Differ       Date:  2001-05       Impact factor: 15.828

10.  Heat induction of the unphosphorylated form of hypoxia-inducible factor-1alpha is dependent on heat shock protein-90 activity.

Authors:  Dorthe M Katschinski; Lu Le; Daniel Heinrich; Klaus F Wagner; Thomas Hofer; Susann G Schindler; Roland H Wenger
Journal:  J Biol Chem       Date:  2002-01-04       Impact factor: 5.157

View more
  4 in total

1.  Impact of N-Terminal Tags on De Novo Vimentin Intermediate Filament Assembly.

Authors:  Saima Usman; Hebah Aldehlawi; Thuan Khanh Ngoc Nguyen; Muy-Teck Teh; Ahmad Waseem
Journal:  Int J Mol Sci       Date:  2022-06-06       Impact factor: 6.208

2.  Expression of Hsp90α and cyclin B1 were related to prognosis of esophageal squamous cell carcinoma and keratin pearl formation.

Authors:  Tingyuan Huang; Size Chen; Hongyu Han; Huadan Li; Zhizhou Huang; Jianming Zhang; Qiangbin Yin; Xiaojie Wang; Xiaojiao Ma; Peijuan Dai; Danping Duan; Fei Zou; Xuemei Chen
Journal:  Int J Clin Exp Pathol       Date:  2014-03-15

3.  Hypoxia attenuates Hsp90 inhibitor 17-DMAG-induced cyclin B1 accumulation in hepatocellular carcinoma cells.

Authors:  Jianming Zhang; Huadan Li; Zhizhou Huang; Yangfan He; Xueqiong Zhou; Tingyuan Huang; Peijuan Dai; Danping Duan; Xiaojiao Ma; Qiangbin Yin; Xiaojie Wang; Hong Liu; Size Chen; Fei Zou; Xuemei Chen
Journal:  Cell Stress Chaperones       Date:  2016-01-20       Impact factor: 3.667

4.  Estrogen mediated protection of cytoskeleton against oxidative stress.

Authors:  Darshini A Ganatra; Kaid S R Johar; Trilok J Parmar; Alpesh R Patel; S Rajkumar; Anshul I Arora; Forum B Kayastha; Anuradha K Pal; Devarshi U Gajjar; Abhay R Vasavada
Journal:  Indian J Med Res       Date:  2013-01       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.